Newborn screening for spinal muscular atrophy improves chances of walking and quality of life: study
Testing in the newborn period is more effective than conventional clinical diagnosis pathways for improving health outcomes in infants wit
top of page
CripChat Australia #198: Beyond the NDIS: Services and Supports for People with Disabilities
Play Video
CripChat Australia #197: Quality and Safeguard Reforms – Will They Protect People with Disabilities?
Play Video
CripChat Australia | On Ableism: Part 1: Discrimination, Prejudice, Intolerance
Play Video
CripChat Australia #181: Senate Inquiry on the NDIS Reform Bill: Bombshells and Revelations
Play Video
Australian Disability Limited
Watch Now
Share
Facebook
Twitter
Pinterest
Tumblr
Copy Link
Link Copied
Send Us your News and/or Sports Tip:
Search
Jonathan Shar
Aug 20, 20204 min read
Evrysdi (risdiplam) for the Treatment of Spinal Muscular Atrophy (SMA)Share
Evrysdi™ (risdiplam) is the first and only oral medication indicated for the treatment of spinal muscular atrophy (SMA) in patients of two m
190 views0 comments
bottom of page